The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group.
The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group.
Hyderabad-based Bharat Biotech
According to the sources, Bharat Biotech which has completed the Phase 2/3 trials of Covid-19 vaccine Covaxin for use in children under 18 years of age has submitted the data to the Central Drugs Standard Control Organisation for its verification and subsequent approval for Emergency Use Authorisation
Nicaragua has authorised two Cuban-made coronavirus vaccines to be used in the Central American nation, the Cuban state-run pharmaceutical corporation BioCubaFarma said on Saturday.
Cuban scientists have developed three vaccines against COVID-19, all of which are waiting to receive official recognition from the World Health Organization.